27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...

$56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues. Already ...

Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical ...

The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for ...

31 March 2025 With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its ...

Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of ...

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of ...

Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental ...

4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...